Breaking Down Boundaries, Enabling Access
Allowing early screening and diagnosis for people around the world
Vivo Surgical is a medical technology developer and manufacturer, pioneering devices that empower clinicians to work safely and more efficiently for better clinical outcomes.
Our proprietary technologies, which encompass areas from in vivo surgical lighting and portable endoscopy to flexible endoscopic robotics, target unmet clinical needs in the hospital and beyond - positively impacting society and improving lives.
Our Products
*ENLYT® is a flexible endoscope dedicated for clinicians to screen for early signs of abnormalities.
* Soft launched at the “Promoting Healthier Connections with the World” Global Conference held at Duke University (USA).
KLARO® is a highly versatile in vivo surgical lighting device that addresses the challenges posed by current conventional lighting modalities.
Unlock Superior Visibility
Our Sustainability Impact
Vivo Surgical is proud to support Plastic Bank – a social enterprise dedicated to
fighting plastic pollution in the ocean.
We have committed to the annual extraction of 1,000 kg of ocean-bound plastic – equivalent to about
10,000 units of our product, KLARO™ or 50,000 plastic bottles annually.
Our Partners and Collaborators
We partner and collaborate with key leaders from healthcare systems, research institutes, government and industry, to accelerate the development of products which improve patients' quality of life.
Certifications
Vivo Surgical guarantees that our medical devices comply with all international safety and
regulatory standards.
We work closely with our development and business partners to ensure that our products and services are of the highest quality.
Awards
Vivo Surgical has been recognised as an Award Winner in the WIPO-IPOS IP For Innovation Awards.
The WIPO-IPOS IP For Innovation Awards 2022 celebrates Singapore enterprises who have achieved outstanding growth through the successful use of intellectual property (IP).
Jointly organised by the Intellectual Property Office of Singapore (IPOS) and the World Intellectual
Property Organization (WIPO), the Awards seek to recognise IP champions who have leveraged the
effective use of IP to innovate, transform and grow their business.
Vivo Surgical has been recognised as one of the Top 4 Grand Prize Finalists in the MedTech Innovator 5th Annual Asia Pacific Competition. Over 400 companies applied to be part of the 2023 Asia Pacific Accelerator Cohort, from which 24 companies were shortlisted to partake the 4-month accelerator program.
As one of the finalists, Vivo Surgical looks forward to gaining valuable insights from the mentorship program and forging strong collaborations with industry stakeholders.